Olympus Previews Ready-to-Use PK System Blood Grouping and Phenotyping Reagents for the PK®7200
Anaheim, CA October 20, 2007- Olympus is previewing new ready-to-use PK Blood Grouping and Phenotyping Reagents for the Olympus PK®7200 Automated Microplate System at this week's AABB Annual Meeting & TXPO 2007. The new reagents, which are presently under review by the FDA, will be manufactured by DIAGAST (France) and are expected to replace the current ready-to-use PK blood grouping reagents sold by Olympus America Inc. in the United States. For added convenience, the antisera and reagent A1 and B red blood cells will be provided ready-to-use. No handling or manipulation of the reagents will be required other than transferring them to the appropriate locations in the PK7200 reagent container.
At the current time the PK System Blood Grouping and Phenotyping Reagents are being previewed and are for research use only, not for use in diagnostic procedures. Market launch is anticipated during the fourth quarter of 2007.
For more information on the Olympus PK System Blood Grouping and Phenotyping Reagents, contact Amy Spizzirri, Olympus America Inc.; phone: 484-896-5244; email firstname.lastname@example.org.
About Olympus Diagnostic Systems Group
Olympus Diagnostic Systems provides innovative solutions that meet the high productivity demands of hospitals, integrated healthcare delivery networks, reference labs, blood banks, physician offices and pharmaceutical labs. Olympus offers the broadest standardized line of random access chemistry-immuno analyzers, along with lab automation systems, blood bank analyzers and reagents. Olympus solutions save laboratories time, maximize productivity, and deliver fast, reliable results.
Olympus is a precision technology leader, creating innovative opto-digital solutions in healthcare, life science and consumer electronics products. Olympus works collaboratively with its customers and its affiliates worldwide to leverage R&D investment in precision technology and manufacturing processes across diverse business lines. These include:
· Gastrointestinal endoscopes, accessories, and minimally invasive surgical products;
· Advanced clinical and research microscopes;
· Lab automation systems, chemistry-immuno and blood bank analyzers and reagents;
· Digital cameras and voice recorders.
Olympus serves healthcare and commercial laboratory markets with integrated product solutions and financial, educational and consulting services that help customers to efficiently, reliably and more easily achieve exceptional results. Olympus develops breakthrough technologies with revolutionary product design and functionality for the consumer and professional photography markets, and also is the leader in gastrointestinal endoscopy and clinical and educational microscopes. For more information, visit www.olympusamerica.com .